| 000 | 01794 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516120333.0 | ||
| 264 | 0 | _c20130509 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0b013e32835a36db _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEnzenmüller, Stefanie | |
| 245 | 0 | 0 |
_aChloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome-mediated apoptosis. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _cJan 2013 |
||
| 300 |
_a14-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCathepsin B _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChloroquine _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aFurans _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Membranes _xdrug effects |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aLysosomal-Associated Membrane Protein 1 _xgenetics |
| 650 | 0 | 4 |
_aLysosomes _xdrug effects |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aGonzalez, Patrick | |
| 700 | 1 | _aDebatin, Klaus-Michael | |
| 700 | 1 | _aFulda, Simone | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 24 _gno. 1 _gp. 14-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0b013e32835a36db _zAvailable from publisher's website |
| 999 |
_c22225256 _d22225256 |
||